WizCommerce | $8,000,000 | (Aug 27, 2025)
Nugen | Undisclosed Amount | (Aug 27, 2025)
AiGent | $6,000,000 | (Aug 27, 2025)
Certified by Founder
Lodge
Shinobi Therapeutics
start up
United States
- South San Francisco, CA
- 13/12/2023
- Series A
- $51,000,000
Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.
- Industry Biotechnology Research
- Website https://www.shinobitx.com/
- LinkedIn https://www.linkedin.com/company/shinobitx/about/
Related People
Dan KempFounder
United States -
New York City Metropolitan Area
Accomplished BioPharma Executive with experience in drug discovery (Novartis), translational and clinical development (Merck), sell-side, buy-side and M&A transactional BD (Takeda), Executive oversight (GammaDelta Therapeutics, Adaptate Therapeutics) and Operational Leadership (Cell Therapies at Takeda).
Peeko | $3,200,000 | (Aug 27, 2025)
Reframe Systems | $20,000,000 | (Aug 27, 2025)
Palabra.ai | $8,400,000 | (Aug 27, 2025)
Lumaegis | $200,000,000 | (Aug 27, 2025)
Aurasell AI | $30,000,000 | (Aug 27, 2025)
Loman AI | $3,500,000 | (Aug 27, 2025)
LO:TECH | $5,000,000 | (Aug 27, 2025)
Therna Biosciences | $10,000,000 | (Aug 27, 2025)
Hades Mining | $6,398,622 | (Aug 27, 2025)
Pageport | $3,300,000 | (Aug 27, 2025)